Synthesis of the highly selective Na+/H+ exchange inhibitors cariporide mesilate and (3-methanesulfonyl-4-piperidino-benzoyl) guanidine methanesulfonate

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 11, 1997, Pages 1204-1207

  Weichert, Andreas ^a   Faber, Sabine ^a   Jansen, Hans W ^a   Scholz, Wolfgang ^a   Lang, Hans J ^a  

^a SANOFI   (France)

Author keywords

(3 Methanesulfonyl 4 piperidino benzoyl) guanidine methanesulfonate; Amiloride; Cariporide mesilate; CAS 149725 40 6; CAS 159138 81 5; HOE 642, synthesis; HOE 694, synthesis; Na+ H+ exchange, inhibition, subtypes

Indexed keywords

(3 METHYLSULFONYL 4 PIPERIDINOBENZOYL)GUANIDINE METHANESULFONATE; AMILORIDE; CARIPORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG SYNTHESIS; IN VITRO STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON SODIUM EXCHANGE;

AMILORIDE; CELL LINE; DIURETICS; ENZYME INHIBITORS; GUANIDINES; SODIUM-HYDROGEN ANTIPORTER; SULFONES;

EID: 0030730573     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. [1a] Karmazyn, M., Ray, M., Haist, J. V., J. Cardiovasc. Pharmacol. 21, 172 (1993);
2. [b] Moffat, M. P., Karmazyn, M., J. Mol. Cell. Cardiol. 25, 959 (1993);
3. [c] Tani, M., Neely, J. R., Circ. Res. 65, 1045 (1989);
4. [d] Meng, H.-P., Maddaford, T. G., Pierce, G. N., Am. J. Physiol. 264, H1831 (1993);
5. [2a] Pierce, G. N., Cole, W. C. Liu, K. et al., Pharmacol. Exp. Ther. 265, 1280 (1993);
6. [b] Garcia, M. L., King, V. F., Shevell, J. L. et al., J. Biol. Chem. 265, 3763 (1990);
7. [c] Lai, Z.-F. Hotokebuchi, N., Cragoe, E. J. et al., Cardiovasc. Pharmacol. 23, 259 (1994)
8. Scholz, W., Albus, U., Linz, W. et al., J. Mol. Cell. Cardiol. 24, 731 (1992)
9. [4a] Scholz, W., Albus, U., Lang, H.-J. et al., Pharmacol. 109, 562 (1993);
10. [b] Counillon, L. T., Scholz, W., Lang, H.-J. et al., Mol. Pharmacol. 44, 1041 (1993);
11. [c] Du Toit, E. F., Opie, L. H., J. Cardiovasc. Pharmacol. 22, 877 (1993);
12. [d] hendrikx, M., Mubagwa. K., Verdonck, F. et al., Circulation 89, 2787 (1994);
13. [e] Sack, S., Mohri, M., Schwarz, E. R. et al., J. Cardiovasc. Pharmacol. 23, 72 (1994);
14. [f] Harper, I. S., Bond, J. M., Chacon, E. et al., Basic Res. Cardiol. 88, 430 (1993);
15. [5a] Scholz, W., Albus, U., Counillon, L. T. et al., Cardiovasc. Res. 29, 260 (1995);
16. [b] Russ, U., Baiser, C., Scholz, W. et al., Pfluegers Arch. 433, 26 (1996);
17. [c] Xue, Y. X., Aye, N. N., Hashimoto, K., Eur. J. Pharmacol. 317, 309 (1996);
18. [d] Miura, T., Ogawa, T., Suzuki, K. et al., J. Am. Coll. Cardiol. 29, 693 (1997)
19. Weichert, A., Bauer, M., Wirsig, P., Synlett 5, 473 (1996)
20. Faber, S., Lang, H.-J., Jansen, H.-W. et al., Pflügers Arch. 431 (Suppl. 6), R26 (1996)